How to submit a paper to the PMI Journal

This page is dedicated to providing you with all the necessary information about submitting a paper to the Journal of Pathology, Microbiology & Immunology. Below, you can find information about our current Call for Papers, Author Guidelines, Open Access Publishing, and other frequently asked questions.

Call for mini-reviews

The PMI Journal  welcomes submissions of mini-reviews, extending a special invitation to contributors where the initial draft has been generated by a junior scientist, such as a postdoctoral researcher, graduate student, or undergraduate student. This inclusive approach aims to foster the development and recognition of emerging talents in the scientific community.

Mini-reviews should be concise, summarizing new and emerging fields and be accessible to non-specialists. 

Mini-reviews offer an excellent opportunity to explore new and emerging fields, providing concise yet comprehensive summaries that are accessible to non-specialists. By submitting a mini-review, you still enjoy all the standard benefits of contributing an article to the PMI Journal. This includes free open access options and the absence of publishing and submission fees.

Manuscript format:

  • Approx. 3000 words (references not included)
  • 1-3 figures/tables
  • Up to 50 references

Why publish with the Journal of Pathology, Microbiology and Immunology?

Submitting your article to the Journal og Pathology, Microbiology and Immunology can offer several compelling reasons:

  • Reputable journal: The Journal og Pathology, Microbiology and Immunology is a well-respected journal in the fields of pathology, microbiology and immunology. Publishing your work in the Journal og Pathology, Microbiology and Immunology can enhance your research’s visibility and credibility within the scientific community.
  • International audience: The Journal og Pathology, Microbiology and Immunology reaches a global readership, increasing the exposure of your research to a broad and diverse audience of researchers, clinicians, and experts in your field.
  • Rigorous peer review: The Journal og Pathology, Microbiology and Immunology maintains high standards of peer review, ensuring that your manuscript undergoes a thorough evaluation by experts in your area of study. This process can help improve the quality of your work and validate its scientific merit.
  • Rapid publication: The Journal og Pathology, Microbiology and Immunology aims to provide a timely publication process, allowing your research findings to be disseminated more quickly compared to some other journals.
  • Interdisciplinary focus: The Journal og Pathology, Microbiology and Immunology covers a wide range of topics within pathology, microbiology and immunology, making it a suitable platform for researchers exploring multidisciplinary aspects of these fields.
  • Open access options: The Journal og Pathology, Microbiology and Immunology offers open access publication options, making your research freely available to a broader audience, potentially increasing its impact. Read more about open access.

Overall, submitting your article to the Journal og Pathology, Microbiology and Immunology can help you reach a global audience, gain recognition in your field, and contribute to the advancement of knowledge in pathology, microbiology and immunology. However, it’s essential to review the specific guidelines and policies of the Journal og Pathology, Microbiology and Immunology to ensure your manuscript aligns with their requirements before submission. Read all about the guidelines by clicking here.

Author Guidelines

Journal of Pathology, Microbiology and Immunology welcomes submissions from authors in the field of pathology, microbiology and immunology, and related areas of modern biomedicine. 

Priority is given to original articles and reviews. Letters to the editor may include comments on articles published or other original contributions of particular interest. Case reports will not be considered for publication. 

The Author Guidelines outline the manuscript formatting requirements, ethical considerations, and the submission process to ensure a smooth and efficient review process for your research. Please review the Author Guidelines carefully before submitting your work to our journal to enhance the quality and accessibility of your research contributions.

What kinds of contributions does the PMI Journal accept?

Priority is given to original articles and reviews. Mini-reviews are also invited for submission. Letters to the editor may include comments on articles published in APMIS or other original contributions of particular interest. Case reports will not be considered for publication.

Original articles are papers that present original and significant material based on primary research. The paper should contain an abstract, main body and references. The length of the main body is flexible and may range from at least 1500 words to a maximum of 6000 words.

Full length papers exceeding 30 pages, as well as theses, monographs, etc., may be published as supplements on acceptance by the editorial board. The author bears the full cost. Further information is available from the editorial office. All submitted manuscripts should have the language revised. Non-native speakers of English are encouraged to consider using a language editing service.

Mini-reviews, including submissions where a junior-scientist (post doc, graduate student or undergraduate student) has generated the first draft, are encouraged. Mini-reviews should be concise, summarizing new and emerging fields and be accessible to non-specialists. Manuscript format is approx. 3000 words (references not included); 1-3 figures/tables; and up to 50 references.

 

Can I submit findings from my PHD Thesis?

Yes. At the PMI Journal, we support submissions from young scientists and have a proud tradition of doing so. We welcome high-quality research contributions within the fields of Pathology, Microbiology, and Immunology. We encourage authors to rework their theses into one or more concise articles that meet our submission guidelines. By doing so, you can share your significant findings with the wider scientific community through our esteemed publication.

Why choose Open Access Publishing?

Journal of Pathology, Microbiology and Immunology is a hybrid journal which offers authors the option to publish their articles open access: immediately free to read, download, and share. 

Open access allows authors to reach a wider audience, increase the impact of their research, comply with funding requirements, and contribute to the global dissemination of knowledge in the fields of pathology, microbiology, and immunology. It’s a beneficial choice for researchers who want to maximize the visibility and accessibility of their work. 

Publishing open access with the Journal of Pathology, Microbiology and Immunology provides several advantages for authors:

Maximum visibility: The Journal of Pathology, Microbiology and Immunology is a reputable journal with a broad readership in the fields of pathology, microbiology, and immunology. Publishing open access ensures that your research is easily accessible to researchers, practitioners, and the general public worldwide, increasing the visibility and impact of your work.

Increased citations: Open access articles are more likely to be cited because they are readily available to a wider audience. This can enhance the academic and professional recognition of your research.

Global reach: The open access option of Journal of Pathology, Microbiology and Immunology allows your work to transcend geographical and institutional barriers. Researchers from diverse backgrounds and locations can easily access and benefit from your findings.

Rapid dissemination: Open access publishing accelerates the dissemination of your research.

Open access transformational agreements: Many institutions around the world have transformational agreements with Wiley, meaning that their articles can be published with open access in the Journal of Pathology, Microbiology and Immunology free of charge. See the list here.

Read more by clicking here